Home > M&A deals 1999 > aPriori Capital Partners LP and Crescentia Capital acquire Charles River Laboratories International, Inc.
Buyout (LBO, MBO, MBI) · Life Science · January 1999

aPriori Capital Partners LP and Crescentia Capital acquire Charles River Laboratories International, Inc.

On January 1, 1999, aPriori Capital Partners LP and Crescentia Capital acquired Charles River Laboratories International, Inc., a life science company in Massachusetts, United States.

Deal at a glance

AnnouncedJanuary 1, 1999 TypeBuyout (LBO, MBO, MBI) TargetCharles River Laboratories International, Inc. Buyers aPriori Capital Partners LP
Crescentia Capital SectorLife Science LocationMassachusetts, United States ValueNot disclosed

Target company

Charles River Laboratories International, Inc.
Massachusetts, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyers (2)

aPriori Capital Partners LP Lead
Private equity firm · 61 deals on record
Crescentia Capital Co-investor
Private equity firm · 75 deals on record
  • 1st transaction for the lead buyer in life science
  • 4th transaction in United States
61deals, all time
8in this sector
2011latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Charles River Laboratories International, Inc.?aPriori Capital Partners LP and Crescentia Capital acquired Charles River Laboratories International, Inc. on January 1, 1999.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector in 1999.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).